Home Cart Sign in  
Chemical Structure| 29949-85-7 Chemical Structure| 29949-85-7

Structure of 29949-85-7

Chemical Structure| 29949-85-7

Tris(3-chlorophenyl)phosphine

CAS No.: 29949-85-7

4.5 *For Research Use Only !

Cat. No.: A808239 Purity: 98%

Change View

Size Price

US Stock

Global Stock

In Stock
250mg łÇÿ¶ÊÊ Inquiry Inquiry
1g ł§Ç¶ÊÊ Inquiry Inquiry
5g łÇÍǶÊÊ Inquiry Inquiry
25g łÍîͶÊÊ Inquiry Inquiry

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 250mg

    łÇÿ¶ÊÊ

  • 1g

    ł§Ç¶ÊÊ

  • 5g

    łÇÍǶÊÊ

  • 25g

    łÍîͶÊÊ

In Stock

- +

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 29949-85-7 ]

CAS No. :29949-85-7
Formula : C18H12Cl3P
M.W : 365.62
SMILES Code : ClC1=CC(P(C2=CC=CC(Cl)=C2)C3=CC=CC(Cl)=C3)=CC=C1
MDL No. :MFCD00013632
InChI Key :QAPGHLJQIVDTPT-UHFFFAOYSA-N
Pubchem ID :121600

Safety of [ 29949-85-7 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Computational Chemistry of [ 29949-85-7 ] Show Less

Physicochemical Properties

Num. heavy atoms 22
Num. arom. heavy atoms 18
Fraction Csp3 0.0
Num. rotatable bonds 3
Num. H-bond acceptors 0.0
Num. H-bond donors 0.0
Molar Refractivity 100.18
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

13.59 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

4.06
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

6.49
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

5.41
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

6.65
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

7.34
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

5.99

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-6.6
Solubility 0.0000912 mg/ml ; 0.000000249 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Poorly soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-6.57
Solubility 0.0000981 mg/ml ; 0.000000268 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Poorly soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-9.34
Solubility 0.000000168 mg/ml ; 0.0000000005 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Poorly soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

Yes
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

Yes
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

Yes
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

Yes
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-3.92 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

1.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

2.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

1.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<2.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

4.18

Application In Synthesis of [ 29949-85-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 29949-85-7 ]

[ 29949-85-7 ] Synthesis Path-Downstream   1~30

  • 1
  • [ 64-17-5 ]
  • [ 29949-85-7 ]
  • [ 127-65-1 ]
  • [ 54300-36-6 ]
  • 2
  • [ 29949-85-7 ]
  • [ 127-65-1 ]
  • [ 54300-36-6 ]
  • 3
  • [ 2892-63-9 ]
  • [ 29949-85-7 ]
  • [ 102268-48-4 ]
  • 4
  • [ 2446-83-5 ]
  • [ 29949-85-7 ]
  • [ 84985-43-3 ]
  • C34H29Cl3N2O7P(1+)*C8H15N2O4(1-) [ No CAS ]
  • 5
  • [ 20057-88-9 ]
  • [ 29949-85-7 ]
  • [ 54300-45-7 ]
  • [ 882-33-7 ]
  • 6
  • [ 29949-85-7 ]
  • [ 76943-18-5 ]
  • C22H16Cl3F6O2P [ No CAS ]
  • 7
  • [ 29949-85-7 ]
  • [ 54300-36-6 ]
YieldReaction ConditionsOperation in experiment
With dihydrogen peroxide; In dichloromethane; at 0 - 20℃; Under the protection of N2, dissolve 1-chloro-3-bromobenzene (5g) in 40mL ultra-dry tetrahydrofuran and put it in a Dewar flask at -78; add n-BuLi(16.4 mL) and stirred for 1h, then added phosphine trichloride (0.75mL), warmed to room temperature, stirred for 8-12 hours; added water (20mL) to quench the butyllithium, then distilled under reduced pressure to remove tetrahydrofuran; then extracted with water and CH2Cl2 Three times, the organic phase was collected and dried with anhydrous Na2SO4, and then distilled under reduced pressure to remove the solvent; finally purified by column chromatography to obtain m-TClPP; m-TClPP was dissolved in CH2Cl2 and placed in an ice-water bath at 0C, slowly dripping Add H2O2 (5 mL), then stir at room temperature for 2-4 hours. It was extracted three times with water and CH2Cl2, the organic phase was collected and dried with anhydrous Na2SO4 to remove water, and then distilled under reduced pressure to remove the solvent to obtain m-TClPPO as a white powder.
  • 8
  • [ 64-17-5 ]
  • [ 29949-85-7 ]
  • sodium-<<i>N</i>-chloro-toluenesulfonamide-(4)-trihydrate [ No CAS ]
  • [ 54300-36-6 ]
  • 10
  • 3-chloro-phenyl magnesium iodide [ No CAS ]
  • [ 29949-85-7 ]
  • 12
  • [ 29949-85-7 ]
  • [ 3474-40-6 ]
  • bis(3-chlorophenyl)phosphinyl radical [ No CAS ]
  • 13
  • [ 114713-40-5 ]
  • [ 29949-85-7 ]
  • Cu(OCC(C(CH3)3)CHC(C(CH3)3)CHCNNC(CH)2CH(CH)2)(P(CCHCCl(CH)3)3)2 [ No CAS ]
  • 14
  • [ 114713-42-7 ]
  • [ 29949-85-7 ]
  • Cu(OCC(C(CH3)3)CHC(C(CH3)3)CHCNNC(CH)2CBr(CH)2)(P(CCHCCl(CH)3)3)2 [ No CAS ]
  • 15
  • [ 114713-45-0 ]
  • [ 29949-85-7 ]
  • Cu(OCC(C(CH3)3)CHC(C(CH3)3)CHCNNC(CH)2COCH3(CH)2)(P(CCHCCl(CH)3)3)2 [ No CAS ]
  • 16
  • bis(acetonitrile)(chloranilato)palladium(II) [ No CAS ]
  • [ 29949-85-7 ]
  • [ 121354-23-2 ]
  • 17
  • [ 132012-57-8 ]
  • [ 29949-85-7 ]
  • Cu(OCC(C(CH3)3)CHC(C(CH3)3)CHCNNCCNO2(CH)4)(P(CCHCCl(CH)3)3)2 [ No CAS ]
  • 18
  • [ 114713-43-8 ]
  • [ 29949-85-7 ]
  • Cu(OCC(C(CH3)3)CHC(C(CH3)3)CHCNNC(CH)2CNO2(CH)2)(P(CCHCCl(CH)3)3)2 [ No CAS ]
  • 19
  • [ 132012-56-7 ]
  • [ 29949-85-7 ]
  • Cu(OCC(C(CH3)3)CHC(C(CH3)3)CHCNNCCCl(CH)4)(P(CCHCCl(CH)3)3)2 [ No CAS ]
  • 20
  • [ 132040-56-3 ]
  • [ 29949-85-7 ]
  • Cu(OCC(C(CH3)3)CHC(C(CH3)3)CHCNNCCBr(CH)4)(P(CCHCCl(CH)3)3)2 [ No CAS ]
  • 21
  • [ 114713-44-9 ]
  • [ 29949-85-7 ]
  • Cu(OCC(C(CH3)3)CHC(C(CH3)3)CHCNNC(CH)2CCH3(CH)2)(P(CCHCCl(CH)3)3)2 [ No CAS ]
  • 22
  • [ 132012-58-9 ]
  • [ 29949-85-7 ]
  • Cu(OCC(C(CH3)3)CHC(C(CH3)3)CHCNNCCOCH3(CH)4)(P(CCHCCl(CH)3)3)2 [ No CAS ]
  • 23
  • [ 1282-37-7 ]
  • [(η(5)-C9H7)(CO)2Fe]2 [ No CAS ]
  • [ 29949-85-7 ]
  • {(C9H7)Fe(CO)2P(Cl(C6H4))3}(1+)*BF4(1-) = {(C9H7)Fe(CO)2P(Cl(C6H4))3}{BF4} [ No CAS ]
  • 24
  • [ 140634-18-0 ]
  • [ 29949-85-7 ]
  • Pt(C6H5)2(CO)(P(C6H4Cl)3) [ No CAS ]
  • 25
  • [ 138459-68-4 ]
  • [ 29949-85-7 ]
  • {Rh2(O2CMe)(μ-O2CMe)2{(C6H4)PPh2}{P(C6H4Cl-m)3}(OH2)} [ No CAS ]
  • 26
  • [2-(dimethylaminomethyl)ferrocenylAu]2 [ No CAS ]
  • [ 29949-85-7 ]
  • [ 206761-27-5 ]
  • 27
  • ((6-(1-methylbenzyl)-2,2'-bipyridyl)PtCl) [ No CAS ]
  • [ 29949-85-7 ]
  • [ 198898-84-9 ]
  • 28
  • [ 494804-05-6 ]
  • [ 29949-85-7 ]
  • 4Rh*11CO*P(C6H4Cl)3=Rh4(CO)11P(C6H4Cl)3 [ No CAS ]
  • 29
  • cis-[Pt(DMSO)2(Me)2] [ No CAS ]
  • [ 29949-85-7 ]
  • [ 196213-71-5 ]
  • 30
  • chloro(1,5-cyclooctadiene)rhodium(I) dimer [ No CAS ]
  • [ 29949-85-7 ]
  • [ 890663-08-8 ]
 

Historical Records

Technical Information

Categories